These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 24282168)
1. Stimulant medication for ADHD not associated with subsequent substance use disorders. Riggs PD Evid Based Med; 2014 Apr; 19(2):78. PubMed ID: 24282168 [No Abstract] [Full Text] [Related]
2. Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence. Poulton A Evid Based Ment Health; 2014 Feb; 17(1):16. PubMed ID: 24104557 [No Abstract] [Full Text] [Related]
3. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. Faraone SV; Wilens TE J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377 [TBL] [Abstract][Full Text] [Related]
4. Does stimulant treatment lead to substance use disorders? Faraone SV; Wilens T J Clin Psychiatry; 2003; 64 Suppl 11():9-13. PubMed ID: 14529324 [TBL] [Abstract][Full Text] [Related]
5. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643 [TBL] [Abstract][Full Text] [Related]
6. Stimulant treatment for ADHD may not increase risk of substance abuse. Harv Ment Health Lett; 2008 Jun; 24(12):7. PubMed ID: 18946888 [No Abstract] [Full Text] [Related]
7. Do conduct problems and sensation seeking moderate the association between ADHD and three types of stimulant use in a college population? Van Eck K; Markle RS; Flory K Psychol Addict Behav; 2012 Dec; 26(4):939-47. PubMed ID: 22428861 [TBL] [Abstract][Full Text] [Related]
8. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study. McCabe SE; Dickinson K; West BT; Wilens TE J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066 [TBL] [Abstract][Full Text] [Related]
14. Stimulant treatment of ADHD and risk of sudden death in children. Vitiello B; Towbin K Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196 [No Abstract] [Full Text] [Related]
16. Stimulant Use Disorders. Park TM; Haning WF Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):461-71. PubMed ID: 27338967 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. Biederman J J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323 [TBL] [Abstract][Full Text] [Related]
18. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Faraone SV; Biederman J; Wilens TE; Adamson J Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106 [TBL] [Abstract][Full Text] [Related]
19. The potential for misuse and abuse of medications in ADHD: a review. Clemow DB; Walker DJ Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651 [TBL] [Abstract][Full Text] [Related]